Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation

European Journal of Immunology

Volumn 29, Issue 9, 1999, Pages 3017-3027

  Li Weber, Min ^a   Laur, Oskar ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; CD95(APO 1 Fas)L promoter

Indexed keywords

ANTIBODY; CYCLOSPORIN A; DNA; DNA BINDING PROTEIN; FAS LIGAND; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BINDING SITE; DNA BINDING; DNA FLANKING REGION; DNA FOOTPRINTING; DNA SEQUENCE; DNA TRANSCRIPTION; ELECTROPHORETIC MOBILITY; GENE MUTATION; GENETIC TRANSFECTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 0033368238     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO;2-R     Document Type: Article

References (42)

1. Oehm, A., Behrmann, l., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B. C., Ponstingl, H. and Krammer, P. H., Purification and molecular cloning of the APQ-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 1992. 267; 10709-10715.
2. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A. and Nagata, S., The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 1992. 148:1274-1278.
3. Suda, J., Takahashi, T., Golstein, P. and Nagata, S., Molecular cloning and expression of the Fas ligand, a novel member of the TNF family. Cell 1993. 75: 1169-1178.
4. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, K. and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995.181: 71-77.
5. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F. and Green, D. R., Cellautomonous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373: 441-444.
6. Dhein, J., Walczak, H., Baümler, C., Debatin, K.-M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/Fas/CD95). Nature 1995. 373: 438-441.
7. Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for .programmed cell death after T-cell activation. Nature (995: 373: 444-448.
8. Kisielow, J. and von Boehmer, H., Development and selection of T cells: facts and puzzles. Adv. Immunol. 1995.58:87-105.
9. Klas, C., Debatin, K.-M., Jonker, R. R. and Krammer, P. H., Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 1993. 5: 625-630.
10. Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Möller, P., Falk, W., Debatin, K. M. and Krammer, P. H., Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989. 245: 301-305.
11. Wesselborg, S., Janssen, O. and Kabelitz, D., Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 1993.150:4388-4345.
12. Yonehara, S., Ishii, A. and Yonehara, M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface receptor antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989.169:1747-1756.
13. Krammer, P. H., CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 1999. 71:163-210.
14. Nagata, S. and Golstein, P., The Fas death factor. Science 1995. 267:1449-1456.
15. Paris, M., Latinis, K. M., Kempiak, S. J., Koretzky, G. A. and Nel, A., Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter. Mol. Cell. Bid. 1998. 18: 5414-5424.
16. Holtz-Heppelmann, C. J., Algeciras, A., Badley, A. D. and Paya, C. V., Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 1998. 273:4414-4423.
17. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A. and Green, D. R., DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kB and AP-1. Mol. Cell 1998.1: 543-551.
18. Latanis, K. M., Norian, L. A., Eliason, S. L. and Koretzky, G. A., Two NF-AT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 1997.272:31247-31434.
19. Li-Weber, M., Laur, O., Hekele, A., Coy, J., Walczak, H. and Krammer, P. H., A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur. J. Immunol. 1998. 28:2373-2383. ;
20. Mittelstadt, P. R. and Ashwell, J. D., Cyclosporin Asènsitive transcription factor Egr-3 regulates Fas ligand expression. Mol. Cell. Biol. 1998.18: 3744-3751.
21. Norian, L. A., Latinis, K. M. and Koretzky, G. A., Cutting edge: A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes. J. Immunol. 1998. 161: 1078-1082.
22. Brunner, T., Nam, J. Y., LaFace, D., Ware, C. F. and Green, D. R., Activation-induced cell death in murine T cell hybridomas: differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int. Immunol. 1996. 8:1017-1062.
23. Flanagan, W. M., Corthesy, B., Bram, R. J. and Crabtree, G. R., Nuclear association of a T-cell transcription factor blocked by FK506 and cyclosporin A. Nature 1991.352:803-807.
24. Rao, A., Luo, C. and Hogan, P. G., Transcription factors of the NF-AT family: regulation and function. Annu. Rev. Immunol. 1997.15: 707-747.
25. Mages, H. W., Stamminger, T., Rilke, O., Bravo, R. and Kroczek, R. A., Expression of PILOT, a putative transcription factor, requires two signals and is cyclosporin A sensitive in T cells. Int. Immunol. 1993. 5: 63-70.
26. Shao, H., Kono, D. H., Chen, L. Y., Rubin, E. M. and Kaye, J., Induction of the early growth response Egr family of transcription factors during thymic selection. J. Exp. Med. 1997.185: 731-744. '
27. Northrop, J. P., Ullman, K. S. and Crabtree, G. R., Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J. Biol. Chem. 1993. 268: 2917-2923.
28. Gashler, A. and Sukhatme, V. P., Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 1995.50:191-224.
29. Skerka, C., Decker, E. L. and Zipfel, P. F., A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and Egr-1. J. Biol. Chem. 1995. 270: 22500-22506.
30. Lin, J. X. and Leonard, W. J., The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites. Mol. Cell. Biol. 1997.17:3714-3722.
31. Maltzman, J. S., Carman, J. A. and Monroe, J. G., Transcriptional regulation of the lcam-1 gene in antigen receptor- and phorbol ester-estimulated B lymphocytes: role for transcription factor Egr1. J. Exp. Med. 1996.183: 1747-1759.
32. Inar, G., Crozat, A. and Pardee, A. B., The immediateearly gene Egr-1 regulates the activity of the thymidine kinase promoter at the GO-to-G1 transition of the cell cycle. Mol. Cell. Biol. 1994.14: 5242-5248.
33. Tourtellotte, W. G. and Milbrandt, J., Sensory ataxia and'muscle spindle agenesis in mice lacking the transcription factor Egr-3. Nat. Genet. 1998. 20: 87-91.
34. Shao, H., Kono, D. H., Chen, L. Y., Rubin, E. M. and Kaye, J., Induction of the early growth response Egr family of transcription factors during thymic selection. J. Exp. Med. 1997.185: 731-744.
35. Rooney, J. W., Sun, A. L., Glimcher, L. H. and Hoey, T., Novel NF-AT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 1995.15: 6299-6310.
36. Szabo, S. J., Gold, J. S., Murphy, T. L. and Murphy, K. M., Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell. Biol. 1993. 13: 4793-4805.
37. Chi, T. and Carey, M., The ZEBRA activation domain: modular organization and mechanism of action. Mol. Cell. Biol. 1993.13: 7045-7055.
38. Pascal, E. and Tjian, R., Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 1991. 5:1646-1656.
39. Tjian, R. and Maniatis, T., Transcriptional activation: a complex puzzle with few easy pieces. Cell 1994.77:5-8.
40. Fiering, S., Northrop, J. P., Nolan, G. P., Mattila, P. S., Crabtree, G. R. and Herzenberg, L. A., Single cell assay of a transcription factor reveals a threshold in transcription activated by signal emanating from the T-cell antigen receptor. Genes Dev. 1990. 4:1823-1834.
41. Northrop, J. P., Ho, S. N., Chen, L., Thomas, D. J., Timmerman, L. A., Nolan, G. P., Admon, A. and Crabtree, G. R., NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 1994.369:497-502.
42. Swirnoff, A. H. and Milbrandt, J., DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol. Cell. Blol. 1995.15: 2275-2287.